* ImmunoTherapeutics Inc., of Fargo, N.D., said it has an option onlicensing patents from Massachusetts Institute of Technology (MIT),in Cambridge, related to use of polymerized liposomes for oraldelivery of drugs and vaccines. Financial terms were not disclosed.The technology was discovered by Robert Langer, a professor ofchemical and biomedical engineering at MIT.
* LXR Biotechnology Inc., of Richmond, Calif., entered acollaboration with Perkin-Elmer Corp., of Norwalk, Conn., fordevelopment of LXR's scanning laser digital imaging technology.The agreement initially is focused on use of the technology forhybridization-based assays. Financial terms of the alliance were notdisclosed. LXR will receive royalties from Perkin-Elmer, which willhave exclusive worldwide rights.
(c) 1997 American Health Consultants. All rights reserved.